First Page | Meta Content | |
---|---|---|
![]() | Document Date: 2012-04-24 10:13:49Open Document File Size: 90,73 KBShare Result on FacebookCityBarcelona / /CompanyEPO / /ContinentEurope / /CountryFrance / /IndustryTermlaw experimental drugs / hepatitis C treatment / /MedicalConditionstandard hepatitis C / recently approved hepatitis C / compensated cirrhosis / Neutropenia / cirrhosis / thrombocytopenia / anemia / serious infections / hepatitis C / HCV / /MedicalTreatmentblood transfusion / /OrganizationCongress / European Association for the Study of the Liver / /PersonMichael Carter Christophe Hézode / Christophe Hézode / Keith Alcorn / /ProductPeginterferon / ribavirin / /SocialTag |